JP2008503540A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008503540A5 JP2008503540A5 JP2007517234A JP2007517234A JP2008503540A5 JP 2008503540 A5 JP2008503540 A5 JP 2008503540A5 JP 2007517234 A JP2007517234 A JP 2007517234A JP 2007517234 A JP2007517234 A JP 2007517234A JP 2008503540 A5 JP2008503540 A5 JP 2008503540A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- rifamycin
- matrix
- colon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2004A001295 | 2004-06-25 | ||
| IT001295A ITMI20041295A1 (it) | 2004-06-25 | 2004-06-25 | Composizioni farmaceutiche antimicrobiche orali |
| PCT/EP2005/052025 WO2006003043A1 (en) | 2004-06-25 | 2005-05-03 | Oral antimicrobial pharmceutical compositions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008039159A Division JP2008163038A (ja) | 2004-06-25 | 2008-02-20 | 経口抗菌医薬組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008503540A JP2008503540A (ja) | 2008-02-07 |
| JP2008503540A5 true JP2008503540A5 (cg-RX-API-DMAC7.html) | 2008-11-06 |
| JP5026262B2 JP5026262B2 (ja) | 2012-09-12 |
Family
ID=34968899
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007517234A Expired - Lifetime JP5026262B2 (ja) | 2004-06-25 | 2005-05-03 | 経口抗菌医薬組成物 |
| JP2008039159A Withdrawn JP2008163038A (ja) | 2004-06-25 | 2008-02-20 | 経口抗菌医薬組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008039159A Withdrawn JP2008163038A (ja) | 2004-06-25 | 2008-02-20 | 経口抗菌医薬組成物 |
Country Status (22)
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8497258B2 (en) | 2005-11-12 | 2013-07-30 | The Regents Of The University Of California | Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| DK2011486T3 (da) † | 2007-07-06 | 2012-09-03 | Lupin Ltd | Farmaceutiske sammensætninger af rifaximin |
| US20100239682A1 (en) * | 2007-09-17 | 2010-09-23 | Antoine Andremont | Colonic delivery of antimicrobial agents |
| KR20190062609A (ko) | 2009-01-12 | 2019-06-05 | 바이오키어 인코포레이티드 | 당뇨병 치료 조성물 및 치료방법 |
| US9006288B2 (en) | 2009-01-12 | 2015-04-14 | Biokier, Inc. | Composition and method for treatment of diabetes |
| US9314444B2 (en) | 2009-01-12 | 2016-04-19 | Biokier, Inc. | Composition and method for treatment of NASH |
| EP2440210A4 (en) | 2009-06-12 | 2014-01-29 | Meritage Pharma Inc | METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES |
| US9301938B2 (en) | 2009-09-23 | 2016-04-05 | Biokier, Inc. | Composition and method for treatment of diabetes |
| WO2012016707A2 (en) * | 2010-08-06 | 2012-02-09 | Ratiopharm Gmbh | Oral dosage form for the modified release of dimebolin |
| US20130259947A1 (en) * | 2010-11-29 | 2013-10-03 | Dr. Reddy's Laboratories Ltd. | Oral metronidazole pharmaceutical compositions |
| FI3706724T3 (fi) | 2017-11-10 | 2024-10-14 | Cosmo Technologies Ltd | Suun kautta otettavia rifamysiini sv -koostumuksia |
| IT202000005782A1 (it) | 2020-03-18 | 2021-09-18 | Dpl Pharma S P A | Formulazioni farmaceutiche a rilascio controllato per il trattamento di infezioni intestinali |
| KR102714380B1 (ko) * | 2021-06-09 | 2024-10-11 | 강원대학교산학협력단 | 경구 투여용 나노입자 및 이의 제조방법 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE458505B (sv) * | 1979-07-10 | 1989-04-10 | Lepetit Spa | Anvaendningen av rifamycin sv och salter daerav foer framstaellning av en beredning foer behandling av reumatoid artrit samt vissa av salterna och deras framstaellning |
| US4409209A (en) * | 1979-10-12 | 1983-10-11 | Ciba-Geigy Corporation | Novel phosphorylmuramyl peptides and processes for the manufacture thereof |
| IT1230576B (it) | 1988-10-20 | 1991-10-28 | Angeli Inst Spa | Formulazioni farmaceutiche per via orale a liberazione selettiva nel colon |
| IE61651B1 (en) * | 1990-07-04 | 1994-11-16 | Zambon Spa | Programmed release oral solid pharmaceutical dosage form |
| IT1260505B (it) | 1992-06-01 | 1996-04-09 | Poli Ind Chimica Spa | Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon |
| CN1097306A (zh) * | 1993-07-12 | 1995-01-18 | 中国医科大学第二临床学院 | 复方抗炎栓剂 |
| US5849327A (en) | 1994-07-29 | 1998-12-15 | Advanced Polymer Systems, Inc. | Delivery of drugs to the lower gastrointestinal tract |
| US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| US6245351B1 (en) * | 1996-03-07 | 2001-06-12 | Takeda Chemical Industries, Ltd. | Controlled-release composition |
| US5985823A (en) | 1997-06-09 | 1999-11-16 | Ambi Inc. | Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon |
| CN1256085C (zh) * | 1997-07-01 | 2006-05-17 | 美国辉瑞有限公司 | 舍曲林盐和舍曲林的缓释剂型 |
| DE19850445A1 (de) | 1998-11-02 | 2000-05-04 | Falk Pharma Gmbh | Arzneimittel zur topischen Behandlung entzündlicher Darmerkrankungen |
| US6248363B1 (en) | 1999-11-23 | 2001-06-19 | Lipocine, Inc. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| GB9910773D0 (en) * | 1999-05-11 | 1999-07-07 | West Pharm Serv Drug Res Ltd | Novel single unit coated dosage forms that can be used to minimise the effect of food on the absorption of drugs from the gastrointestinal tract |
| JP4790950B2 (ja) | 1999-06-14 | 2011-10-12 | コスモ・テクノロジーズ・リミテッド | 制御放出および味感遮蔽経口医薬組成物 |
| JP4393098B2 (ja) | 2002-06-21 | 2010-01-06 | 独立行政法人科学技術振興機構 | アンサマイシン系抗生物質の新規用途及び新規血管新生抑制物質のスクリーニング方法 |
| CN1201736C (zh) * | 2002-07-19 | 2005-05-18 | 安徽省药物研究所 | 甲硝唑结肠定位缓释制剂 |
| EA008150B1 (ru) * | 2002-08-26 | 2007-04-27 | С. Л. А. Фарма Аг | Фармацевтическая композиция |
| WO2005030173A1 (en) | 2003-09-25 | 2005-04-07 | Ranbaxy Laboratories Limited | Colon-specific drug delivery using interpolymer complexations |
-
2004
- 2004-06-25 IT IT001295A patent/ITMI20041295A1/it unknown
-
2005
- 2005-05-03 RS RSP-2008/0241A patent/RS50581B/sr unknown
- 2005-05-03 AT AT05749954T patent/ATE392889T1/de active
- 2005-05-03 DK DK05749954T patent/DK1763339T3/da active
- 2005-05-03 WO PCT/EP2005/052025 patent/WO2006003043A1/en not_active Ceased
- 2005-05-03 HR HR20080252T patent/HRP20080252T3/xx unknown
- 2005-05-03 SI SI200530254T patent/SI1763339T1/sl unknown
- 2005-05-03 CA CA002628005A patent/CA2628005A1/en not_active Abandoned
- 2005-05-03 CN CN2005800206291A patent/CN1976685B/zh not_active Expired - Lifetime
- 2005-05-03 EP EP07122775A patent/EP1894560A1/en not_active Withdrawn
- 2005-05-03 EP EP05749954A patent/EP1763339B1/en not_active Expired - Lifetime
- 2005-05-03 PT PT05749954T patent/PT1763339E/pt unknown
- 2005-05-03 KR KR1020087012947A patent/KR20080059337A/ko not_active Withdrawn
- 2005-05-03 CN CNA2008101001129A patent/CN101317826A/zh active Pending
- 2005-05-03 ZA ZA200610577A patent/ZA200610577B/en unknown
- 2005-05-03 US US11/571,044 patent/US8486446B2/en not_active Expired - Fee Related
- 2005-05-03 JP JP2007517234A patent/JP5026262B2/ja not_active Expired - Lifetime
- 2005-05-03 ES ES05749954T patent/ES2303255T3/es not_active Expired - Lifetime
- 2005-05-03 DE DE602005006278T patent/DE602005006278T2/de not_active Expired - Lifetime
- 2005-05-03 MX MXPA06014698A patent/MXPA06014698A/es active IP Right Grant
- 2005-05-03 KR KR1020067027024A patent/KR101157486B1/ko not_active Expired - Lifetime
- 2005-05-03 CA CA2569683A patent/CA2569683C/en not_active Expired - Lifetime
- 2005-05-03 PL PL05749954T patent/PL1763339T3/pl unknown
-
2008
- 2008-02-20 JP JP2008039159A patent/JP2008163038A/ja not_active Withdrawn
- 2008-06-05 US US12/133,568 patent/US20080233193A1/en not_active Abandoned
- 2008-07-14 CY CY20081100739T patent/CY1108196T1/el unknown
-
2012
- 2012-04-19 US US13/451,111 patent/US8263120B2/en not_active Expired - Lifetime
- 2012-08-22 US US13/592,097 patent/US20120316229A1/en not_active Abandoned
- 2012-08-22 US US13/592,088 patent/US8741948B2/en not_active Expired - Lifetime
- 2012-09-14 US US13/616,582 patent/US8529945B2/en not_active Expired - Fee Related
-
2014
- 2014-08-28 US US14/471,509 patent/US20140370093A1/en not_active Abandoned
-
2019
- 2019-03-01 US US16/289,748 patent/US20190192441A1/en not_active Abandoned
- 2019-05-28 FI FIC20190031C patent/FIC20190031I1/fi unknown
- 2019-07-08 HU HUS1900037C patent/HUS1900037I1/hu unknown
-
2020
- 2020-12-07 US US17/114,057 patent/US20210093576A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008163038A5 (cg-RX-API-DMAC7.html) | ||
| AU2009266833B2 (en) | Melt granulation process | |
| JP2008503540A5 (cg-RX-API-DMAC7.html) | ||
| JP5918242B2 (ja) | リファキシミンを含む医薬処方物、それを得るための方法及び腸疾患を治療する方法 | |
| JP2018507200A5 (cg-RX-API-DMAC7.html) | ||
| JP2007528901A5 (cg-RX-API-DMAC7.html) | ||
| RU2744576C2 (ru) | Пероральные фармацевтические композиции месалазина | |
| JP2011503048A5 (cg-RX-API-DMAC7.html) | ||
| CN104114163A (zh) | 治疗心血管疾病的方法 | |
| CA2569683A1 (en) | Oral antimicrobial pharmaceutical compositions | |
| JP2022520170A (ja) | アファビシン製剤、その作製方法及びその使用 | |
| ES2417330T3 (es) | Minicomprimidos farmacéuticos para la liberación sostenida de acetato de flecainida | |
| JP2017502062A5 (cg-RX-API-DMAC7.html) | ||
| WO2013169925A1 (en) | Novel formulations of nitrofurans including nifurtimox with enhanced activity with lower toxicity | |
| RU2018137323A (ru) | Пероральные фармацевтические композиции никотинамида | |
| WO2016147108A1 (en) | Pharmaceutical compositions of dimethyl fumarate | |
| CA2833115C (en) | Pharmaceutical compositions of raltegravir, methods of preparation and use thereof | |
| WO2012123922A1 (en) | Controlled release pharmaceutical compositions of selective serotonin reuptake inhibitor | |
| WO2017093444A1 (en) | Compositions for oral administration in the treatment of inflammatory bowel disease | |
| US20200054659A1 (en) | Extended release capecitabine capsules | |
| WO2016001843A1 (en) | Extended-release gastroretentive tablets of voglibose | |
| WO2020115774A1 (en) | High drug load extended release formulations | |
| JPWO2022271765A5 (cg-RX-API-DMAC7.html) | ||
| WO2023067485A1 (en) | Pharmaceutical combinations | |
| WO2018142359A1 (en) | Composition comprising immediate release and extended release capecitabine |